Pharmerica Corp (PMC) - Financial and Strategic SWOT Analysis Review

Date: June 28, 2017
Pages: 45
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PE9BE259968EN
Leaflet:

Download PDF Leaflet

Pharmerica Corp (PMC) - Financial and Strategic SWOT Analysis Review
Pharmerica Corp (PMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pharmerica Corp (PharMerica) is an institutional pharmacy services company. It offers healthcare facilities and provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting. PharMerica’s services include long term care pharmacy services, alternate care, e-ordering and e-prescribing, products and billing programs, consultant pharmacist services, paper and electronic medical record services, account service and field services. Its solutions cater to the customers including institutional healthcare providers such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care and other long-term alternative care providers. PharMerica is headquartered in Louisville, Kentucky, the US.

Pharmerica Corp Key Recent Developments

May 10,2017: PharMerica Reports First Quarter 2017 Results
Feb 24,2017: PharMerica Reports Fourth Quarter and Full Year 2016 Results
Jan 31,2017: PharMerica Appoints Robert E. Dries as Executive Vice President and Chief Financial Officer
Dec 15,2016: PharMerica Announces Expansion of Existing Credit Facility, Increasing Borrowing Capacity by $150 Million
Nov 09,2016: PharMerica Reports Third Quarter 2016 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Pharmerica Corp - Key Facts
Pharmerica Corp - Key Employees
Pharmerica Corp - Key Employee Biographies
Pharmerica Corp - Major Products and Services
Pharmerica Corp - History
Pharmerica Corp - Company Statement
Pharmerica Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Pharmerica Corp - Business Description
Pharmerica Corp - Corporate Strategy
Pharmerica Corp - SWOT Analysis
SWOT Analysis - Overview
Pharmerica Corp - Strengths
Pharmerica Corp - Weaknesses
Pharmerica Corp - Opportunities
Pharmerica Corp - Threats
Pharmerica Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Pharmerica Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 10, 2017: PharMerica Reports First Quarter 2017 Results
Feb 24, 2017: PharMerica Reports Fourth Quarter and Full Year 2016 Results
Jan 31, 2017: PharMerica Appoints Robert E. Dries as Executive Vice President and Chief Financial Officer
Nov 09, 2016: PharMerica Reports Third Quarter 2016 Results
Aug 09, 2016: PharMerica Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr.
Aug 09, 2016: PharMerica Reports Second Quarter 2016 Results
May 06, 2016: PharMerica Reports First Quarter 2016 Results
Apr 04, 2016: PharMerica Provides Update on AmerisourceBergen Litigation
Feb 26, 2016: PharMerica Reports Fourth Quarter and Full Year 2015 Results

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Pharmerica Corp, Key Facts
Pharmerica Corp, Key Employees
Pharmerica Corp, Key Employee Biographies
Pharmerica Corp, Major Products and Services
Pharmerica Corp, History
Pharmerica Corp, Other Locations
Pharmerica Corp, Subsidiaries
Pharmerica Corp, Key Competitors
Pharmerica Corp, Ratios based on current share price
Pharmerica Corp, Annual Ratios
Pharmerica Corp, Annual Ratios (Cont...1)
Pharmerica Corp, Annual Ratios (Cont...2)
Pharmerica Corp, Interim Ratios
Pharmerica Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Pharmerica Corp, Performance Chart (2012 - 2016)
Pharmerica Corp, Ratio Charts

COMPANIES MENTIONED

Standard Management Corporation
Rite Aid Corp
Owens & Minor Inc
Omnicare Inc
McKesson Corp
HealthWarehouse.com Inc
CVS Health Corporation
Skip to top


Ask Your Question

Pharmerica Corp (PMC) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: